Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 39Observational 5Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Other solid neoplasm 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 28Carcinoma, Renal Cell 7Pancreatic Neoplasms 6Ovarian Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Sarcoma 4Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Breast Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 3Melanoma 3Stomach Neoplasms 2Rhabdoid Tumor 2Prostatic Neoplasms, Castration-Resistant 2Head and Neck Neoplasms 2Glioblastoma 2Chondrosarcoma 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Wilms Tumor 1Urologic Neoplasms 1Urogenital Neoplasms 1Thyroid Neoplasms 1Sarcoma, Synovial 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Prostatic Diseases 1

Interventions

omburtamab I-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Hepatoblastoma × Genitourinary × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡